MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is unlike virtually every other research peptide in one fundamental respect: it is encoded not by nuclear DNA, but by mitochondrial DNA. Discovered in 2015 by Changhan David Lee and colleagues at USC, its identification reshaped thinking about mitochondria as signalling organelles — not merely cellular power plants.

The peptide's discovery emerged from a re-examination of the 12S rRNA gene in mitochondrial DNA, which was assumed to encode only structural RNA. Hidden within this sequence was a small open reading frame encoding a 16-amino acid peptide. This "moonlighting" function — a known non-coding region actually encoding a bioactive molecule — opened an entirely new dimension of mitochondria-to-nucleus communication research.

MOTS-c's primary mechanism involves translocation from the mitochondria to the nucleus in response to metabolic stress. Once in the nucleus, it acts as a transcriptional regulator, reprogramming gene expression to increase cellular stress resistance and metabolic flexibility. This retrograde signalling — from organelle to nucleus — is a form of communication that researchers are still mapping in detail.

Metabolic regulation is the best-characterized function of MOTS-c. Studies in mouse models have shown that MOTS-c administration activates AMPK (AMP-activated protein kinase), a master energy sensor. This activation drives increased glucose uptake in skeletal muscle, improved insulin sensitivity, and reduced adipogenesis. Importantly, these effects have been observed even without changes in food intake, suggesting direct metabolic reprogramming.

Exercise biology represents an exciting application of MOTS-c research. Plasma levels of MOTS-c rise acutely during exercise in humans — a discovery that positions it as an exercise-mimetic candidate. Studies comparing MOTS-c levels in young versus elderly subjects show an age-related decline in circulating MOTS-c, mirroring the reduced metabolic flexibility that characterises aging. Whether exogenous MOTS-c can substitute for this exercise-associated rise is a key question driving ongoing research.

Longevity research has produced particularly compelling data. A 2019 study published in Cell Metabolism showed that MOTS-c administration extended lifespan in aged mice and improved physical performance on multiple functional tests. The treated animals also showed reduced incidence of age-related metabolic pathology.

Nuclear genetics research has added another layer of complexity. Polymorphisms in the MOTS-c coding sequence have been associated with longevity in human populations — specifically in studies of Japanese centenarians, where certain MOTS-c variants are enriched compared to younger controls. This is direct genomic evidence linking MOTS-c biology to human longevity.

For researchers sourcing MOTS-c, the 16-amino acid sequence must be precisely verified. Given the relatively recent characterisation of this peptide, fewer reference standards exist compared to more established compounds. Mass spectrometry with sequence confirmation (not just molecular weight) is the appropriate verification standard. HPLC purity above 98% is standard for research applications.

MOTS-c exemplifies the expanding frontier of peptide research — where the biological complexity of a single molecule opens research programmes spanning mitochondrial biology, nuclear gene regulation, exercise physiology, and geroscience simultaneously.